Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 13, 2023

SELL
$21.54 - $24.41 $45,729 - $51,822
-2,123 Reduced 53.48%
1,847 $41,000
Q4 2022

Jan 24, 2023

SELL
$13.92 - $17.0 $1,308 - $1,598
-94 Reduced 2.31%
3,970 $0
Q3 2021

Oct 12, 2021

BUY
$17.38 - $21.54 $70,632 - $87,538
4,064 New
4,064 $82,000

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Harbor Investment Advisory, LLC Portfolio

Follow Harbor Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.